Skip to main navigation Skip to search Skip to main content

A Phase II Multicentre Open-Label Trial of Tagraxofusp (TAG) In Combination with Venetoclax and Azacitidine (VEN/AZA) In Adults with Previously untreated CD123+ Acute Myeloid Leukemia (AML) who are Ineligible for Intensive Chemotherapy

Project: Research

Project Details

StatusActive
Effective start/end date5/08/25 → 4/08/30

Clinical Trial Phase

  • Phase II